Metraipolis › archive › dc_ecf64b44ac8e
Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42542683
- DOI
- 10.1016/j.esmorw.2026.100748
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T15:16:23.929Z
- SHA-256 of the archived text
a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508- Stable URL of this page
https://metraipolis.com/documento/dc_ecf64b44ac8e
How to cite
Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683 — Europe PMC (en), https://europepmc.org/article/MED/42542683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecf64b44ac8e (Metraipolis archive dc_ecf64b44ac8e, sha256 a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508)
BibTeX
@misc{dcecf64b44ac8e,
title = {Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries — Europe PMC PMID:42542683},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42542683},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecf64b44ac8e; sha256 a84910e15a6dab9d5de937fbf8ce34df218f21917f7c34740b2d3f0d219c7508},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42542683. Agents can read the archived copy with the MCP tool read_document.